Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 55, 2021 - Issue 2
Journal homepage
1,137
Views
1
CrossRef citations to date
0
Altmetric
Articles

Preoperative predictors of pathological tumour stage and prognosis may be used when selecting candidates for intensified treatment in upper tract urothelial carcinoma

Bjarte Almåsa Department of Urology, Haukeland University Hospital, Bergen, NorwayCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4484-040X
ORCID Icon,
Stein Øverbyb Department of Urology, Vestfold Hospital Trust, Tønsberg, Norway
,
Ole J. Halvorsenc Department of Clinical Medicine, University of Bergen, Bergen, Norway;d Department of Clinical Medicine, Section for Pathology, Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway
,
Lars A. R. Reisætere Department of Radiology, Haukeland University Hospital, Bergen, Norway
,
Birgitte Carlsenf Department of Pathology, Vestfold Hospital Trust, Tønsberg, Norway
&
Christian Beislanda Department of Urology, Haukeland University Hospital, Bergen, Norway;c Department of Clinical Medicine, University of Bergen, Bergen, NorwayORCID Iconhttps://orcid.org/0000-0002-3216-4937
ORCID Icon
Pages 100-107 | Received 07 Sep 2020, Accepted 12 Jan 2021, Published online: 01 Feb 2021

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
  • Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115(6):1224–1233.
  • Abouassaly R, Alibhai SM, Shah N, et al. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology. 2010;76(4):895–901.
  • Birtle A, Johnson M, Chester J, et al. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Lancet. 2020;395(10232):1268–1277.
  • Matin SF, Margulis V, Kamat A, et al. Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer. 2010;116(13):3127–3134.
  • Inokuchi J, Kuroiwa K, Kakehi Y, et al. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A. World J Urol. 2017;35(11):1737–1744.
  • Seisen T, Krasnow RE, Bellmunt J, et al. Effectiveness of adjuvant chemotherapy after radical nephroureterectomy for locally advanced and/or positive regional lymph node upper tract urothelial carcinoma. J Clin Oncol. 2017;35(8):852–860.
  • Rouprêt M, Babjuk M, Comperat E, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol. 2018;73(1):111–122.
  • Eble JN, Sauter G, Epstein JI. Pathology & genetics of tumors of the urinary system and male genital organs. Lyon (France): IARC Press; 2004.
  • Brierly JG, Wittekind C. TNM classification of malignant tumors. 8th ed. Oxford (UK): Wiley Blackwell; 2017.
  • Breda A, Territo A, Sanguedolce F, et al. Comparison of biopsy devices in upper tract urothelial carcinoma. World J Urol. 2019;37(9):1899–1905.
  • Subiela JD, Territo A, Mercadé A, et al. Diagnostic accuracy of ureteroscopic biopsy in predicting stage and grade at final pathology in upper tract urothelial carcinoma: systematic review and meta-analysis. Eur J Surg Oncol. 2020;46:1989–1997.
  • Marchioni M, Primiceri G, Cindolo L, et al. Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis. BJU Int. 2017;120(3):313–319. Sep
  • Guo RQ, Hong P, Xiong GY, et al. Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis. BJU Int. 2018;121(2):184–193.
  • Alfred Witjes J, Lebret T, Compérat EM, et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2017;71(3):462–475.
  • Favaretto RL, Shariat SF, Savage C, et al. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int. 2012;109(1):77–82. Jan
  • Yu SH, Hur YH, Hwang EC, et al. Does multidetector computed tomographic urography (MDCTU) T staging classification correspond with pathologic T staging in upper tract urothelial carcinoma? Int Urol Nephrol. 2021;53(1):69–75.
  • Petros FG, Qiao W, Singla N, et al. Preoperative multiplex nomogram for prediction of high-risk nonorgan-confined upper-tract urothelial carcinoma. Urol Oncol. 2019;37(4):292.e1–292–e9.
  • Lughezzani G, Jeldres C, Isbarn H, et al. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology. 2010;75(1):118–124.
  • Rouprêt M, Hupertan V, Seisen T, et al. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. J Urol. 2013;189(5):1662–1669. May
  • Lughezzani G, Jeldres C, Isbarn H, et al. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. Eur J Cancer. 2009;45(18):3291–3297.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.